NO993928L - Farmasöytisk blanding for oral administrasjon av heterosykliske forbindelser i form av kvaternær ammonium - Google Patents

Farmasöytisk blanding for oral administrasjon av heterosykliske forbindelser i form av kvaternær ammonium

Info

Publication number
NO993928L
NO993928L NO993928A NO993928A NO993928L NO 993928 L NO993928 L NO 993928L NO 993928 A NO993928 A NO 993928A NO 993928 A NO993928 A NO 993928A NO 993928 L NO993928 L NO 993928L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
weight
quaternary ammonium
oral administration
heterocyclic compounds
Prior art date
Application number
NO993928A
Other languages
English (en)
Other versions
NO993928D0 (no
Inventor
Jean-Claude Gautier
Xavier Boulenc
Regine Bellamy
Bernard Abramovici
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO993928D0 publication Critical patent/NO993928D0/no
Publication of NO993928L publication Critical patent/NO993928L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Oppfinnelsen angår et farmasøytisk preparat for oral administrering av heterocykliske forbindelser i form av kvaternært ammonium, inneholdende aktivt prinsipp hydrofilt løsemiddel anionisk overflateaktivt middel polysorbat 80 makrogoglycerid QS opptil 0,1 tiM5vekt% O til 60 vekt% O til 5 vekt% O til 5 vekt% 100vekt%, forutsatt at minst en bestanddel valgt fra det hydrofile løsemiddel og anioniske overflateaktive middel er til stede.
NO993928A 1997-02-17 1999-08-16 Farmasöytisk blanding for oral administrasjon av heterosykliske forbindelser i form av kvaternær ammonium NO993928L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701825A FR2759584B1 (fr) 1997-02-17 1997-02-17 Composition pharmaceutique pour l'administration orale de composes heterocycliques sous forme ammonium quaternaire
PCT/FR1998/000298 WO1998035662A1 (fr) 1997-02-17 1998-02-17 Composition pharmaceutique pour l'administration orale de composes heterocycliques sous forme ammonium quaternaire

Publications (2)

Publication Number Publication Date
NO993928D0 NO993928D0 (no) 1999-08-16
NO993928L true NO993928L (no) 1999-08-16

Family

ID=9503804

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993928A NO993928L (no) 1997-02-17 1999-08-16 Farmasöytisk blanding for oral administrasjon av heterosykliske forbindelser i form av kvaternær ammonium

Country Status (11)

Country Link
EP (1) EP0969825A1 (no)
JP (1) JP2001511795A (no)
AR (1) AR011805A1 (no)
AU (1) AU6404998A (no)
BR (1) BR9807694A (no)
CA (1) CA2281560A1 (no)
FR (1) FR2759584B1 (no)
HR (1) HRP980075A2 (no)
NO (1) NO993928L (no)
WO (1) WO1998035662A1 (no)
ZA (1) ZA981289B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102188424B (zh) * 2011-03-23 2013-03-27 浙江理工大学 Sr140333的抗血癌作用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2688219B1 (fr) * 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
FR2696178B1 (fr) * 1992-09-30 1994-12-30 Sanofi Elf Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant.
FR2717804B1 (fr) * 1994-03-25 1996-06-21 Sanofi Sa Sels de composés hétéroaromatiques azotés substitués, procédé pour leur préparation et compositions pharmaceutiques en contenant.
CN1067385C (zh) * 1994-08-25 2001-06-20 默里尔药物公司 用于治疗变应性疾病的新的取代的哌啶类化合物
FR2725986B1 (fr) * 1994-10-21 1996-11-29 Adir Nouveaux derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2725900B1 (fr) * 1994-10-21 1997-07-18 Sanofi Sa Utilisation d'antagonistes des recepteurs nk1 pour la preparation de medicaments a action cardioregulatrice
FR2729951B1 (fr) * 1995-01-30 1997-04-18 Sanofi Sa Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
EP0969825A1 (fr) 2000-01-12
NO993928D0 (no) 1999-08-16
WO1998035662A1 (fr) 1998-08-20
HRP980075A2 (en) 1998-10-31
AR011805A1 (es) 2000-09-13
JP2001511795A (ja) 2001-08-14
FR2759584A1 (fr) 1998-08-21
ZA981289B (en) 1998-08-26
FR2759584B1 (fr) 1999-06-11
BR9807694A (pt) 2000-03-21
AU6404998A (en) 1998-09-08
CA2281560A1 (en) 1998-08-20

Similar Documents

Publication Publication Date Title
NO954146L (no) Belagte farmasöytiske preparater
FR2677984B1 (fr) Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
FI973320A (fi) Kiinteitä aktiiviainetta sisältäviä valmisteita
DK0449247T3 (da) Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme
NO304989B1 (no) 11<beta>-benzaldoksim-°stra-4,9-dienderivater samt farmas°ytisk preparat inneholdende slike
NO20000466L (no) Farmasøytisk preparat for sure, lipofile forbindelser i form av en selvregulerende formulering
DE69307977D1 (de) Stabilisierte Derivate von Vitamin D2 und D3 enthaltende pharmazeutische Zusammensetzungen
GR1002295B (el) Στερεες φαρμακευτικες συνθεσεις και μεθοδος για την παρασκευη τους.
DK515489D0 (da) Dispergerbar laegemiddelformulering
DK0648779T3 (da) 11-benzaldoxim-17beta-methoxy-17alfa-methoxymethyl-estradien-derivater, fremgangsmåder til deres fremstilling og lægemidler indeholdende disse forbindelser
PT1078627E (pt) Formulacao farmaceutica compreendendo amoxicilina e clavulanato
HU9300202D0 (en) Benzo-pyrane derivatives, pharmaceutical preparatives containing them as active substance as well as method for producing them
NO993928L (no) Farmasöytisk blanding for oral administrasjon av heterosykliske forbindelser i form av kvaternær ammonium
ATE316788T1 (de) Medikament gegen pulmonale herzprobleme
DK0624365T3 (da) Farmaceutisk form til rectal administrering af farmakologisk aktive forbindelser
IT1272762B (it) Derivati benz/e/indenici farmaceuticamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
DK0986390T3 (da) Farmaceutiske præparater med cinchosin-dihydrochlorid
DE69000806D1 (de) Indol-derivate.
ATE335491T1 (de) Arzneimittel gegen glomerulosclerose
FR2659967B1 (fr) Derives d'imidazolinone n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
ITMI911653A1 (it) Derivati dell'eseridina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT9022371A0 (it) Derivati dell'1-arilsolfonil 2-pirrolidone, loro procedimento di preparazione e i nuovi intermedi cosi' ottenuti, il loro impiego come farmaci e le composizioni farmaceutiche che li contengono.
ATE181828T1 (de) Oral anzuwendendes arzneimittel bestehend aus ibuprofen
ITMI912324A1 (it) Derivati dall'acido beta-idrossibutirrico, procedimento per la loro preparazione e relative composizioni farmaceutiche.
NO950484D0 (no) 3- og 5-substituerte 1,2,3,4-oksatriazol-5-iminforbindelser, fremgangsmåte for fremstilling derav, farmasöytisk preparat inneholdende forbindelsene samt anvendelse av slike for fremstilling av medikamenter